Uncategorized
What you need to know about hantavirus (don’t panic)
Good morning. Yesterday, the writer Yiyun Li won a Pulitzer Prize for her heartbreaking memoir, “Things in Nature Merely Grow.” Lately, I’ve been reading her short stories. Here’s one for after you’ve read the news, about a health care worker of sorts: “A Sheltered Woman.”
The latest on the abortion pill
A Monday order from the Supreme Court, signed by Justice Samuel Alito, temporarily restored broad access to mifepristone after a federal appeals court ruling on Friday jeopardized access to the abortion medication at pharmacies or through the mail. The Supreme Court order will remain in effect until the end of the day next Monday, giving both sides time to respond while the court considers the issue. The AP has more details.
Good morning. Yesterday, the writer Yiyun Li won a Pulitzer Prize for her heartbreaking memoir, “Things in Nature Merely Grow.” Lately, I’ve been reading her short stories. Here’s one for after you’ve read the news, about a health care worker of sorts: “A Sheltered Woman.”
The latest on the abortion pill
A Monday order from the Supreme Court, signed by Justice Samuel Alito, temporarily restored broad access to mifepristone after a federal appeals court ruling on Friday jeopardized access to the abortion medication at pharmacies or through the mail. The Supreme Court order will remain in effect until the end of the day next Monday, giving both sides time to respond while the court considers the issue. The AP has more details.
Uncategorized
Vertex earnings get muted investor response
While overall revenue fell just shy of Wall Street forecasts, sales of the gene editing medicine Casgevy and pain drug Journavx missed analyst estimates by double-digit percentages.
While overall revenue fell just shy of Wall Street forecasts, sales of the gene editing medicine Casgevy and pain drug Journavx missed analyst estimates by double-digit percentages.
Uncategorized
Vertex’s quiet Q1 is calm before potentially ‘iconic’ renal evolution
While some analysts may regard Vertex Pharmaceuticals’ first quarter results as “unremarkable,” BMO Capital Markets wrote on Monday, the second half of 2026 could be big for the biotech, with the potential approval of IgAN therapy povetacicept.
Uncategorized
Foundayo’s liver failure blip weighs down Lilly shares. but analysts unconcerned
The selloff in Eli Lilly’s shares was “overdone,” according to RBC Capital Markets, which noted that the overall safety profile of Foundayo remains favorable.
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years agoThe final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years agoAccording to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years agoUber and Lyft are finally available in all of New York State
-
Uncategorized9 years agoPhillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years agoThe old and New Edition cast comes together to perform
-
Uncategorized9 years agoSteph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years agoDisney’s live-action Aladdin finally finds its stars